Ondine Biomedical (LON:OBI) Trading Down 4.9% – What’s Next?

Ondine Biomedical Inc. (LON:OBI) shares dropped 4.9% during mid-day trading on Wednesday . The stock traded as low as C$10.15 and last traded at C$10.70. Approximately 747,902 shares traded hands during mid-day trading, an increase of 161% from the average daily volume of 287,017 shares. The stock had previously closed at C$11.25.

Ondine Biomedical Price Performance

The stock’s fifty day moving average is C$12.33 and its 200-day moving average is C$13.12. The stock has a market capitalization of C$5.54 billion, a PE ratio of -1.53 and a beta of 0.10. The company has a debt-to-equity ratio of 25.95, a current ratio of 1.36 and a quick ratio of 8.26.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.